Article
Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease
1 Feb 2002
Abstract excerpt
Resistance to human immunodeficiency virus type 1 protease (HIV PR) inhibitors results primarily from the selection of multiple mutations in the protease region. Because many of these mutations are selected for the ability to decrease inhibitor binding in the active site, they also affect substrate binding and potentially substrate specificity. This work investigates the substrate specificity of a panel of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
